| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40K | -51.8% |
| R&D Expense | $3.6M | +19.5% |
| SG&A Expense | $4.8M | +186.8% |
| Operating Income | -$58.2M | -715.4% |
| Interest Expense | $2.5M | -2.1% |
| Net Income | -$62.1M | -422.3% |
| EPS (Basic) | -$3.20 | -363.8% |
| EPS (Diluted) | -$3.20 | -363.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59K | -9.5% |
| Current Assets | $1.4M | -37.4% |
| Total Assets | $2.8M | -17.4% |
| Current Liabilities | $20.0M | +124.6% |
| Total Liabilities | $20.3M | +127.9% |
| Stockholders' Equity | -$17.5M | -218.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | -383.3% |
| Investing Cash Flow | -$500K | — |
| Financing Cash Flow | $20.9M | +391.1% |